The Biocodex Microbiota Foundation is announcing the 2024 open call for applications for its annual USA research grant.
| 8th Annual $50,000 Grant to be Awarded to a US-Based Early Researcher for the Study of Gut Microbiota in Human Health and Disease BEDMINSTER, N.J., June 25, 2024 /PRNewswire/ -- The Biocodex Microbiota Foundation, an independent organization founded by Biocodex, is announcing the 2024 open call for applications for its annual USA research grant. The $50,000 grant, now in its 8th year, is juried by a panel of medical and scientific experts. It will be awarded to a US-based investigator studying gut microbiota in human health and disease. The application can be downloaded here in the Rules section under “How to Apply.” The deadline for entry is October 1, 2024.
The Biocodex Microbiota Foundation US grant theme for 2024 is “Gut Microbiota in Human Health and Disease, focusing on groundbreaking research areas such as circadian rhythms, neurological conditions, metabolic disorders, and oncology.” The grant will be awarded in early December and may be applied to a new or ongoing study. It can also be used to fund all or a portion of the research project. “Grants provided by the Foundation reinforce our commitment to supporting early career researchers and their projects,” said Marie Emmanuel LeGuern, President, Biocodex Microbiota Foundation. “Microbiome research is a cornerstone for redefining health and disease, paving the way for revolutionary therapeutic strategies and improved patient outcomes. We are proud of the impact the grant has had on our past US recipients, many of them having published their research and adding to the breadth of microbiota discoveries in scientific literature.” Dr. Shahla Bari, Assistant Professor in GU Oncology at Duke Cancer Institute, the recipient of the 2023 grant, is advancing her research in immuno-oncology with an emphasis on investigating gut microbiome and metabolome as a predictor and modulator of response to immunotherapy. “Winning the Biocodex Microbiota Foundation grant is not just a personal milestone, but a pivotal step in our journey to understand and harness the power of microbiota in cancer treatment,” said Dr. Bari. “This funding accelerates our research, driving us closer to equitable and groundbreaking therapeutic strategies for all patients.” The ideal grant candidate is a US-based researcher with five or fewer years of research experience in microbiota seeking to establish themselves as an independent researcher. All completed applications must be sent to USAFoundation@biocodex.com by the October 1, 2024, deadline. Late or incomplete applications or those that do not meet the grant program or research topic criteria will not be considered. The Biocodex Microbiota Foundation’s annual call for grant applications is part of a multi-year research initiative to understand the interaction between microbiota and different pathologies. The applications will be reviewed, and a recipient selected by the US Biocodex Microbiota Foundation’s scientific board, comprised of Dr. Ruth Ann Luna from Texas Children’s Hospital and Baylor College of Medicine, Dr. Mindy Engevik from the Medical University of South Carolina and Dr. Erica Sonnenburg from Stanford University. About the Biocodex Microbiota Foundation The foundation’s primary activity remains the awarding of annual grants to innovative scientific research projects that explore the structure and impact of microbiota. In addition, the foundation also runs and helps establish programs to improve our understanding of microbiota and disseminates this knowledge as widely as possible, including scientific communities and via public projects aimed to help improve human health. The Biocodex Microbiota Foundation is a non-profit, general-interest organization. For more information or questions about the USA Call for Projects email: USFoundation@Bicodex.com
SOURCE Biocodex Microbiota Foundation |
View original content to download multimedia:
